Home
On-Demand
Industrie
FAQ
Home
On-Demand
Industrie
FAQ
Schlagwort
Augmentation therapy
COPD
COPD
Alpha 1-Antitrypsinmangel
/
Antitrypsin replacement therapy
/
Augmentation therapy
/
Burden of RSV
/
Cardiovascular outcomes
/
Clinical Practice Research Datalink
/
COPD
/
Dupilumab
/
Ensifentrine – dual PDE3/4 inhibitor
/
FEV1
/
GOLD E
/
kardiovaskuläre Primär-Prävention
/
Leicester Cough Questionnaire
/
PRISm
